Merck Life Sciences Acquires HUB Organoids

Date:
HUB organoids, merck

The Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding B.V. (HUB) following regulatory clearances and the fulfilment of other customary closing conditions. The acquisition, which closed on December 23, 2024, is a strategic step aligned with the company’s commitment to providing novel next-generation biology solutions to the life science industry, specifically by enabling wider access to HUB’s technology for more faster and more effective drug development. Terms of the deal were not disclosed.

“The use of organoids offers tremendous potential to improve the drug discovery process,” said Jean-Charles Wirth, Head of Science & Lab Solutions for the Life Science business of Merck KGaA, Darmstadt, Germany. “HUB’s advanced technology, combined with our cell culture expertise and broad portfolio, makes us a valuable resource for researchers looking to leverage the power of 3D cell culture to understand the impact of drug response earlier in the development process.”

HUB possesses the foundational patent portfolio on organoids and a robust service offering ranging from new model generation to assay development and high-throughput screening, enhancing Merck KGaA, Darmstadt, Germany´s offering of cell culture tools to academia, biotech, and pharma customers. The team of approximately 70 employees is celebrating the acquisition together at the HUB campus in Utrecht, Netherlands.

About the Life Science business of Merck KGaA, Darmstadt, Germany

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 28,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

Nieuwe kassen Botanische Tuinen Universiteit Utrecht

Design and start of construction for new greenhouses at the Botanical Gardens announced

The design for the new greenhouse complex of the Botanical Gardens has been finalized, the construction partners have been selected and preparations for construction will start in November 2026. This brings the realization of the new complex one step closer. Construction is scheduled for spring 2027.

Senior civil servants from the Ministries of Economic Affairs and Climate Policy (EZK) and Health, Welfare and Sport (VWS) visit Utrecht Science Park to exchange knowledge on improving prevention, healthcare and economic earning capacity.

How can we ensure that innovations reach patients more effectively and quickly, while also contributing to the Netherlands’ future earning capacity? This question was at the heart of a visit by senior civil servants from the Ministry of Economic Affairs and Climate Policy and the Ministry of Health, Welfare and Sport to Utrecht Science Park on Friday, 30 October.

2.5-hectare new nature reserve at Utrecht Science Park opened

In an area where education, healthcare, housing and research compete for space, 2.5 hectares – equivalent to seven football pitches – of new nature has been created. A 1.6-kilometre-long ‘green corridor’ connects Utrecht Science Park with the surrounding nature reserves, enhances biodiversity and makes the area more attractive to plants and animals.

His Majesty the King visits large-scale exercise at the Major Incident Hospital at Utrecht Science Park: prepared together for major emergencies

On Saturday, October 31, a large-scale exercise took place at the Major Incident Hospital at the Utrecht Science Park. During the exercise, dubbed “Dubbelspoor” (Dual Track), the Major Incident Hospital had to respond to two major incidents almost simultaneously. In Amersfoort, a train carrying thirty injured Dutch military personnel arrived. At nearly the same time, a coach plowed into a crowd during a Halloween celebration. His Majesty the King also visited both locations, marking the 35th anniversary of the Major Incident Hospital.